Unstable EEG-vigilance in patients with cancer-related fatigue (CRF) in comparison to healthy controls

World Journal of Biological Psychiatry

Volumn 13, Issue 2, 2012, Pages 146-152

  Olbrich, Sebastian ^a   Sander, Christian ^a   Jahn, Ina ^a   Eplinius, Franziska ^a   Claus, Sylke ^b   Mergl, Roland ^a   Schönknecht, Peter ^a   Hegerl, Ulrich ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Biological psychiatry; Cancer related fatigue; Depression; EEG vigilance; Neuropsychiatry

Indexed keywords

ADULT; ALERTNESS; ARTICLE; BREAST CANCER; CANCER FATIGUE; COLON CANCER; CONTROLLED STUDY; DROWSINESS; ELECTROENCEPHALOGRAM; FEMALE; HODGKIN DISEASE; HUMAN; KIDNEY CANCER; MALE; OVARY CANCER; SLEEP; SLEEP QUALITY; SOMNOLENCE; TESTIS CANCER; UTERINE CERVIX CANCER; WAKEFULNESS;

ADULT; ALGORITHMS; AROUSAL; CASE-CONTROL STUDIES; ELECTROENCEPHALOGRAPHY; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; POLYSOMNOGRAPHY; SLEEP; SLEEP STAGES;

EID: 84856698255     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2010.545434     Document Type: Article

References (48)

1. Argyropoulos SV, Wilson SJ. 2005. Sleep disturbances in depression and the effects of antidepressants. Int Rev Psychiatr 17:237-245. (Pubitemid 40942996)
2. Auret KA, Schug SA, Bremner AP, Bulsara M. 2009. A randomized, double-blind, placebo-controlled trial assessing the impact of dexamphetamine on fatigue in patients with advanced cancer. J Pain Symptom Manag 37:613-621.
3. Barri è re J, Cherikh F, Pringuey D, Milano G, Ferrero JM. 2008. Antidepressants in oncology: issues and clinical perspectives. B Bull Cancer: 95:1103-1111.
4. Begr é S, Federspiel A, Kiefer C, Schroth G, Dierks T, Strik WK. 2003. Reduced hippocampal anisotropy related to anterioriza-tion of alpha EEG in schizophrenia. Neuroreport 14:739-742. (Pubitemid 36570933)
5. Benca RM, Obermeyer WH, Larson CL, Yun B, Dolski I, Kleist KD, et al. 1999. EEG alpha power and alpha power asymmetry in sleep and wakefulness. Psychophysiology 36:430-436. (Pubitemid 29337186)
6. Bente D. 1964. Vigilanz, dissoziative Vigilanzverschiebung und Insuffizienz des Vigilit ä tstonus. In: Kranz H and Heinrich K (Editors) Begleitwirkungen und Mi ß erfolge der psychiatrischen Pharmakotherapie. Thieme, Stuttgart. p. 13-28.
7. Bruera E, Roca E, Cedaro L, Carraro S, Chacon R. 1985. Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 69:751-754. (Pubitemid 15229409)
8. Cella D, Peterman A, Passik S, Jacobsen P, Breitbart W. 1998. Progress toward guidelines for the management of fatigue. Oncology 12:369-377.
9. Cella D, Davis K, Breitbart W, Curt G. 2001. Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a united states sample of cancer survivors. J Clin Oncol 19:3385-3391. (Pubitemid 32642191)
10. Connemann BJ, Mann K, Lange-Asschenfeldt C, Ruchsow M, Schreckenberger M, Bartenstein P, et al. 2005. Anterior limbic alpha-like activity: a low resolution electromagnetic tomography study with lorazepam challenge. Clin Neurophysiol 116:886-894. (Pubitemid 40432006)
11. Corsi-Cabrera M, Guevara MA, Del Río-Portilla Y, Arce C, Vil-lanueva-Hern á ndez Y. 2000. EEG bands during wakefulness, slow-wave and paradoxical sleep as a result of principal component analysis in man. Sleep 23:738-744.
12. De Gennaro L, Ferrara M. 2003. Sleep spindles: an overview. Sleep Med Rev 7:423-440. (Pubitemid 37221986)
13. De Gennaro L, Ferrara M, Bertini M. 2001a. The boundary between wakefulness and sleep: quantitative electroencephalo-graphic changes during the sleep onset period. Neuroscience 107:1-11. (Pubitemid 34020680)
14. De Gennaro L, Ferrara M, Curcio G, Cristiani R. 2001b. Antero-posterior EEG changes during the wakefulness-sleep transition. Clin Neurophysiol 112:1901-1911. (Pubitemid 32831530)
15. De Gennaro L, Vecchio F, Ferrara M, Curcio G, Rossini PM, Babiloni C. 2004. Changes in fronto-posterior functional coupling at sleep onset in humans. J Sleep Res 13:209-217. (Pubitemid 39331181)
16. De Gennaro L, Vecchio F, Ferrara M, Curcio G, Rossini PM, Babilon CI. 2005. Antero-posterior functional coupling at sleep onset: changes as a function of increased sleep pressure. Brain Res Bull 65:133-140. (Pubitemid 40348798)
17. Görtelmeyer R. SF-A und SF-B. Schlaffragebogen A und B. In CIPS (Eds.), Internationale Skalen für Psychiatrie (2. Edition). 1981; Weinheim: Beltz Test.
18. Guilleminault C, Poyares D, Da Rosa A, Kirisoglu C, Almeida T, Lopes MC. 2006. Chronic fatigue, unrefreshing sleep and nocturnal polysomnography. Sleep Med 7:513-520. (Pubitemid 44296354)
19. Hoddes E, Zarcone V, Smythe H, Phillips R, Dement WC. 1973. Quantification of sleepiness: a new approach. Psychophysiology 10:431-436.
20. Hubain P, Le Bon O, Vandenhende F, Van Wijnendaele R, Linkowski P. 2006. Major depression in males: effects of age, severity and adaptation on sleep variables. Psychiatr Res 145:169-177. (Pubitemid 44739047)
21. Jean-Pierre P, Morrow GR, Roscoe JA, Heckler C, Mohile S, Janelsins M, et al. 2010. A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy. Cancer 116:3513-3520.
22. Lehmann D. 1987. Principles of spatial analysis. In: Gevins AS, R é mond A, editors. Methods of analysis of brain electrical and magnetic signals. Amsterdam: Elsevier. p 309-354.
23. Levy MR. 2008. Cancer fatigue: a neurobiological review for psychiatrists. Psychosomatics 49:283-291. (Pubitemid 351905201)
24. Lin JMS, Brimmer DJ, Maloney EM, Nyarko E, BeLue R, Reeves WC. 2009. Further validation of the Multidimensional Fatigue Inventory in a US adult population sample. Popul Health Metr 7:18.
25. Loomis A, Harvey E, Hobart G. 1937. Cerebral states during sleep, as studied by human brain potentials. J Exp Psychol 21:127-144.
26. Lower EE, Fleishman S, Cooper A, Zeldis J, Faleck H, Yu Z, Manning D. 2009. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial. J Pain Symptom Manag 38:650-662.
27. Ludwig H, Van Belle S, Barrett-Lee P, Birgegård G, Bokemeyer C, Gascón P, et al. 2004. The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. European Journal of Cancer, 40:2293-2306. (Pubitemid 39348881)
28. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. 2008. A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. J Natl Cancer I 100: 1155-1166.
29. Minton O, Richardson A, Sharpe M, Hotopf M, Stone P. 2010. Drug therapy for the management of cancer-related fatigue. Cochrane Database of Systematic Reviews (Online) 7.
30. Morrow GR, Hickok JT, Roscoe JA, Raubertas RF, Andrews PLR, Flynn PJ, et al. 2003. Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program. J Clin Oncol 21:4635-4641. (Pubitemid 46594038)
31. Moss EL, Simpson JSA, Pelletier G, Forsyth P. 2006. An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psycho-Oncology 15:259-267.
32. Olbrich S, Mulert C, Karch S, Trenner M, Leicht G, Pogarell O, et al. 2009. EEG-vigilance and BOLD effect during simultaneous EEG/fMRI measurement. Neuroimage 45:319-332.
33. Olbrich S, Jödicke J, Sander C, Himmerich H, Hegerl U. 2011. ICA-based muscle artefact correction of EEG data: What is muscle and what is brain? Comment on McMenamin et al. Neuroimage 54:1-3.
34. Pariante CM, Lightman SL. 2008. The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31:464-468.
35. Patarca R, Klimas NG, Lugtendorf S, Antoni M, Fletcher MA. 1994. Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome: interrelations with cellular sources and patterns of soluble immune mediator expression. Clin Infect Dis 18:147-153.
36. Roscoe JA, Kaufman ME, Matteson-Rusby SE, Palesh OG, Ryan JL, Kohli S, et al. 2007. Cancer-related fatigue and sleep disorders. Oncologist 12:35-42.
37. Roth B. 1961. The clinical and theoretical importance of EEG rhythms corresponding to states of lowered vigilance. Electro-encephalogr Clin Neurol 13:395-399.
38. Ryan JL, Carroll JK, Ryan EP, Mustian KM, Fiscella K, Morrow GR. 2007. Mechanisms of cancer-related fatigue. Oncologist 12:22-34.
39. Santamaria J, Chiappa KH. 1987. The EEG of drowsiness in normal adults. J Clin Neurophysiol 4:327-382.
40. Schroeder MJ, Barr RE. 2000. An alpha modulation index for electroencephalographic studies using complex demodulation. Med Biol Eng Comput 38:306-310. (Pubitemid 30352927)
41. Sherlin L, Budzynski T, Budzynski HK, Congedo M, Fischer ME, Buchwald D. 2007. Low-resolution electromagnetic brain tomography (LORETA) of monozygotic twins discordant for chronic fatigue syndrome. Neuroimage 34:1438-1442. (Pubitemid 46187080)
42. Stasi R, Abriani L, Beccaglia P, Terzoli E, Amadori S. 2003. Cancer-related fatigue. Cancer 98:1786-1801.
43. Tanaka H, Hayashi M, Hori T. 1996. Statistical features of hypnagogic EEG measured by a new scoring system. Sleep 19:731-738. (Pubitemid 27044518)
44. Tanaka H, Hayashi M, Hori T. 1997. Topographical characteristics and principal component structure of the hypnagogic EEG. Sleep 20:523-534. (Pubitemid 27415475)
45. Tsuno N, Shigeta M, Hyoki K, Kinoshita T, Ushijima S, Faber PL, et al. 2002. Spatial organization of EEG activity from alertness to sleep stage 2 in old and younger subjects. J Sleep Res 11:43-51. (Pubitemid 34227214)
46. Ulrich G, Fürstenberg U. 1999. Quantitative assessment of dynamic electroencephalogram (EEG) organization as a tool for subtyping depressive syndromes. Eur Psychiatry 14:217-229.
47. Wang XS. 2008. Pathophysiology of cancer-related fatigue. Clin J Oncol Nurs 12:11-20.
48. Wittchen HU. 1994. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 28:57-84.